Mineralys Therapeutics Secures $120 Million Financing to Boost Drug Development - MyChesCo
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing novel therapies, announced this week that it has secured approximately $120 million in private placement financing, …
Timothy Alexander
